34704058|t|Dual concentration-dependent effect of ascorbic acid on PAP(248-286) amyloid formation and SEVI-mediated HIV infection.
34704058|a|Human semen contains various amyloidogenic peptides derived from Prostatic Acid Phosphatase (PAP) and Semenogelin proteins that are capable of enhancing HIV-1 infection when assembled into fibrils. The best characterized among them is a 39 amino acid peptide PAP(248-286), which forms amyloid fibrils termed SEVI (semen-derived enhancer of viral infection) that increase the infectivity of HIV-1 by orders of magnitude. Inhibiting amyloid formation by PAP(248-286) may mitigate the sexual transmission of HIV-1. Several vitamins have been shown to reduce the aggregation of amyloids such as Abeta, alpha-Synuclein, and Tau, which are associated with neurodegenerative diseases. Since ascorbic acid (AA, vitamin C) is the most abundant vitamin in semen with average concentrations of 0.4 mM, we here examined how AA affects PAP(248-286) aggregation in vitro. Using ThT binding assays, transmission electron microscopy, and circular dichroism spectroscopy, a dual and concentration-dependent behavior of AA in modulating PAP(248-286) fibril formation was observed. We found that low molar ratios of AA:PAP(248-286) promoted whereas high molar ratios inhibited PAP(248-286) fibril formation. Accordingly, PAP(248-286) aggregated in the presence of low amounts of AA enhanced HIV-1 infection, whereas excess amounts of AA during aggregation reduced the infectivity enhancing effect in cell culture. Collectively, this work provides a biophysical insight into the effect of AA, an important seminal component, on SEVI fibrillation which might impact amyloid formation kinetics, thereby modulating the biological activity of semen amyloids.
34704058	39	52	ascorbic acid	Chemical	MESH:D001205
34704058	56	59	PAP	Gene	55
34704058	69	76	amyloid	Disease	MESH:C000718787
34704058	105	118	HIV infection	Disease	MESH:D015658
34704058	120	125	Human	Species	9606
34704058	185	211	Prostatic Acid Phosphatase	Gene	55
34704058	213	216	PAP	Gene	55
34704058	273	288	HIV-1 infection	Species	
34704058	379	382	PAP	Gene	55
34704058	405	412	amyloid	Disease	MESH:C000718787
34704058	448	475	enhancer of viral infection	Disease	MESH:D014777
34704058	510	515	HIV-1	Species	11676
34704058	551	558	amyloid	Disease	MESH:C000718787
34704058	572	575	PAP	Gene	55
34704058	625	630	HIV-1	Species	11676
34704058	711	716	Abeta	Gene	351
34704058	718	733	alpha-Synuclein	Gene	6622
34704058	739	742	Tau	Gene	4137
34704058	770	796	neurodegenerative diseases	Disease	MESH:D019636
34704058	804	817	ascorbic acid	Chemical	MESH:D001205
34704058	823	832	vitamin C	Chemical	MESH:D001205
34704058	943	946	PAP	Gene	55
34704058	984	987	ThT	Chemical	MESH:C121030
34704058	1139	1142	PAP	Gene	55
34704058	1220	1223	PAP	Gene	55
34704058	1278	1281	PAP	Gene	55
34704058	1322	1325	PAP	Gene	55
34704058	1392	1407	HIV-1 infection	Species	
34704058	1665	1672	amyloid	Disease	MESH:C000718787
34704058	1745	1753	amyloids	Disease	MESH:C000718787
34704058	Association	MESH:D019636	6622
34704058	Association	MESH:C000718787	55
34704058	Association	MESH:D001205	MESH:D015658
34704058	Association	MESH:D019636	351
34704058	Association	MESH:D019636	4137
34704058	Association	MESH:D001205	MESH:C000718787

